Avid Bioservices Inc (CDMO)

[geocappy1]

Dia76, I wish it were true, however, see below in response to my email to IR

We are sorry that your prior communication did not reach us. It was always likely that we would have initial results available from the bavitxumab Phase II breast cancer trial in India before additional data was availalble from the Georgia breast cancer study. We expect updated information from the bavitxumab Georgia trial to be available in the coming months, but an exact date is not available at this time

While the results of Peregrine's trials have been encouraging, Peregrine is careful to observe Nasdaq and FDA industry guidelines and practices by not including overly optimistic or promotional language when presenting early data. Not to do so would risk our credibility with key audiences we need to work with on an ongoing basis, and any short term gain would be outweighed by long term damage to our prospects.

Thank you for your interest in and support of Peregrine

In response to:

I am now emailing you for the second time. My 1st email went unanswered. I have over __ shares of PPHM and I would appreciate the courtesy of a response. Could you please tell me when I can expect some updated info on the PH II results in the Georgia cancer trials? This info should have been available prior to the most recently released trial results from India . Also, could you give me an idea as to why PPHM's depiction of results in their PRs seems to be so tempered even though the results we have been seeing compare favorably to Avasin?